Electromedical Technologies, Inc. (EMED) Research

Electromedical Technologies, Inc. operates within the U.S. market, specializing in the creation and distribution of bioelectronic medical devices specifically designed for pain management. The company's primary product is WellnessPro Plus, a prescription-based bioelectronic therapy tool utilized by both individual users and healthcare professionals to mitigate various forms of discomfort, including both persistent (chronic) and sudden (acute) pain. Established in 2002, the firm is headquartered in Scottsdale, Arizona.

Market snapshot

Symbol
EMED
Price
$0.00
Day change
0.00%
Market cap
$85.5K
P/E ratio
-0.20x
52-week range
0.00005-0.0002
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • BioLife Sciences Inc. (BLFE)
  • Banyan Corp. (BNYN)
  • CBD Life Sciences Inc. (CBDL)
  • Cognetivity Neurosciences Ltd. (CGNSF)
  • Hemp Naturals, Inc. (HPMM)
  • Invion Limited (IVIXF)
  • Rimrock Gold Corp. (RMRK)
  • ScripsAmerica, Inc. (SCRCQ)

Recent insider activity

  • Hymers III R. Leslie — A-Award (35000000 shares) on 2023-02-06
  • Hymers III R. Leslie — trade (0 shares) on 2022-12-20
  • Benson Lee — A-Award (1658999 shares) on 2022-11-02
  • Benson Lee — trade (0 shares) on 2022-09-29
  • STEINBERG DONALD J — S-Sale (57417 shares) on 2021-07-08

Open Electromedical Technologies, Inc. (EMED) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.